Position in GRAL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,852,736
-$4,448,091 QoQ
Shares Held
55,200
-35.3% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $772,811,905 across 28 Diagnostics & Research names. GRAL ranks #17 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
504,668 | $242,336,526 | |
| 2 | DHR |
Danaher Corp /De/
|
678,808 | $128,701,996 | |
| 3 | ILMN |
Illumina, Inc.
|
972,642 | $119,887,852 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
138,964 | $68,304,974 | |
| 5 | NTRA |
Natera, Inc.
|
197,500 | $39,498,025 | |
| 6 | A |
Agilent Technologies, Inc.
|
300,300 | $34,228,194 | |
| 7 | GH |
Guardant Health, Inc.
|
337,600 | $31,184,112 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
48,504 | $27,253,912 |
All Filings in GRAL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,852,736 | 55,200 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,300,827 | 85,300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,096,303 | 103,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,892,970 | 153,500 | Shares | Sole | 2025-08-13 | |
| 2024-06-30 | $934,557 | 60,804 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||